Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

STXS

STXS News

Newswire

15:28

Stereotaxis Director Buys 30,000 Shares at $2.24-$2.18/Share

12:46

Stereotaxis: Roth Capital reiterates Buy, raises PT to $4 from $4.

05:03

Stereotaxis Q3 loss widens, shares drop 12% despite GenesisX limited launch

16:02

Stereotaxis Reports Q3 2025 Financial Results with $7.5M Revenue, Expects Continued Growth.

16:11

FDA Clears GenesisX Robotic Magnetic Navigation System for Minimally Invasive Endovascular Interventions

View More

About STXS

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More